¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"radioisotope renal clearance method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • renal calculus
    ÄáÆÏµ¹, ½ÅÀå°á¼®
  • renal calyx
    ÄáÆÏÀÜ, ½Å¹è
  • renal cancer
    ÄáÆÏ¾Ï, ½ÅÀå¾Ï
  • renal cast
    ÄáÆÏ¿øÁÖ
  • renal cell carcinoma
    ÄáÆÏ¼¼Æ÷¾ÏÁ¾, ½ÅÀå¼¼Æ÷¾ÏÁ¾
  • renal column
    ÄáÆÏ±âµÕ, ½ÅÀå¿øÁÖ
  • renal cortex
    ÄáÆÏ°ÑÁú, ½ÅÀåÇÇÁú
  • renal cortical necrosis
    ÄáÆÏ°ÑÁú±«»ç, ½ÅÀåÇÇÁú±«»ç
  • renal crisis
    ÄáÆÏÀ§±â
  • renal cyst
    1. ÄáÆÏ³¶, ½ÅÀå³¶ 2. ÄáÆÏ³¶Á¾, ½ÅÀå³¶Á¾
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • renal failure
    ÄáÆÏ±â´É»ó½Ç, ½ÅºÎÀü
  • renal function test
    ÄáÆÏ±â´É°Ë»ç, ½ÅÀå±â´É°Ë»ç
  • renal glycosuria
    ÄáÆÏ´ç´¢, ½ÅÀ强´ç´¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • renal vascular disorder
    ÄáÆÏÇ÷°üÀå¾Ö, ½ÅÀåÇ÷°üÀå¾Ö
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷Àå·ù·®
  • renal arteriovenous fistula
    ÄáÆÏµ¿Á¤¸Æ»û±æ, ½ÅÀ嵿Á¤¸Æ·ç
  • renal glycosuria
    ÄáÆÏ´ç´¢
  • renal ablation glomerulosclerosis
    ÄáÆÏÀýÁ¦Å丮±»À½Áõ, ½ÅÀýÁ¦»ç±¸Ã¼°æÈ­Áõ
  • renal hematuria
    ÄáÆÏÇ÷´¢
  • renal hemophilia
    ÄáÆÏÇ÷¿ìº´, ½ÅÀåÇ÷¿ìº´
  • renal hypertension
    ÄáÆÏ°íÇ÷¾Ð
  • renal impression
    ÄáÆÏÀÚ±¹, ½ÅÀå¾ÐÈç
  • renal solute load
    ÄáÆÏ¿ëÁúºÎÇÏ, ½ÅÀå¿ëÁúºÎÇÏ
  • necrotizing renal papillitis
    ±«»çÄáÆÏÀ¯µÎ¿°
  • renal nanism
    ÄáÆÏ³­ÀåÀÌÁõ
  • renal cortical necrosis
    ÄáÆÏ°ÑÁú±«»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Maitlands culture method
    ¸¶ÀÌÆ®·£µå¹è¾ç¹ý
  • Mancini method
    ¸¸½Ã´Ï¹ý
  • Octoson scanning method
    ¿ÁÅä¼Õ ½ºÄµ¹ý (Ûö)
  • Proetz displacement method
    ÇÁ·ÚÃ÷ġȯ¹ý
  • Quellung method
    ÆØÃ¢¹ý(ø³óìÛö).
  • Quellung method
    ÆØÃ¢¹ý(ø³óìÛö).
  • Rothera method
    ·ÎÅ×¶ó¹ý
  • Schoenheimer-Sperry method
    ½¨ÇÏÀ̸Ó-½ºÆä¸® ¹æ¹ý
  • Shihabi-Bishop method
    ½ÃÇϺñ-ºñ¼ó ¹æ¹ý
  • Spinner method
    ½ºÇdzÊ(¹æ)¹ý
  • Tietz-Fiereck method
    ƼÂÅ-ÇÇ·º¹æ¹ý
  • Valsalva method
    ¹ß»ì¹Ù¹ý
  • Wintrobe hematocrit method
    À©Æ®·ÎºêÇ츶ÅäÅ©¸®Æ®¹ý
  • Zebra-stripe imaging method
    ¾ó·è¸» ¹«´Ì ¿µ»ó ¹æ¹ý
  • Zeeman correction method
    Áö¸¸±³Á¤¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mucociliary clearance
    Á¡¾×¼¶¸ð û¼Ò´É
  • occlusal clearance
    ±³ÇÕ°£°Ý.
  • osmol clearance
    »ïÅõ¾ÐŬ¸®¾î·±½º<--û¼ÒÀ²>
  • osmolar clearance
    »ïÅõ¾Ð(ß¶÷âäâ)Ŭ¸®¾î·±½º<û¼ÒÀ²>.
  • osmolar clearance
    ¿À½º¿ç Ŭ¸®¾î·±½º<û¼ÒÀ²>.
  • pneumonia,alveolar clearance in
    ÆóÆ÷ûÁ¤(øËøàôèïä)
  • pneumonia,nasal clearance in
    ¡­ÀÇ ºñûÁ¤
  • urea clearance
    ¿ä¼ÒŬ¸®¾î·±½º, ¿ä¼Òû¼ÒÀ²(èñáÈôèá·ëÒ)
  • urea clearance
    ¿ä¼ÒŬ¸®¾î·±½º, ¿ä¼Òû¼ÒÀ²(èñáÈôèá·ëÒ).
  • xylose clearance test
    ½Ç·Î½ºÃ»¼Ò½ÃÇè(¡­ôèá·ãËúÐ).
  • acid hematin method
    »êÇ츶ƾ¹ý(¡­Ûö).
  • acquisition method
    ȹµæ ¹æ¹ý
  • activated sludge method
    Ȱ¼º¿À´Ï¹ý(Ì·ËÛËçËöËÑ).
  • actuarial method
    º¸ÇèÅë°è¹ý
  • agar diffusion method
    ÇÑõ(³»)È®»ê¹ý.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • high-temperature-short-time method
    °í¿Â ´Ü½Ã°£¹ý(ÍÔè®Ó­ãÁÊàÛö)
  • isotope derivative method
    µ¿À§¿ø¼ÒÀ¯µµÃ¼¹ý(ÔÒêÈêªáÈë¯Óôô÷Ûö)
  • jump method
    ¶Ù±â ¹æ¹ý(Û°Ûö)
  • Kjeldahl method
    Ű¿¤´Þ¹ý(Ûö)
  • label triangulation method
    Ç¥Áö»ï°¢È­¹ý(øöò½ß²ÊÇûùÛö)
  • Lowry method
    ·Î¿ì¸®¹ý(Ûö)
  • low-temperature heat method
    Àú¿Â¿­¹ý(î¸è®æðÛö)
  • LTH method
    LTH¹ý(Ûö)
  • matrix method
    ¸ÅÆ®¸¯½º¹ý(Ûö)
  • Maxam-Gilbert method
    ¸·»ï-±æ¹öÆ®¹ý(Ûö)
  • maximum height-area method
    Ãִ뱤¿ª¹ý(õÌÓÞÎÆæ´Ûö)
  • Merrifield method
    ¸Þ¸®Çʵå¹ý(Ûö)
  • method of continuous variation
    ¿¬¼Óº¯È­¹ý(Ö§áÙܨûùÛö)
  • method of optimal proportions
    ÀûÁ¤ºÎºÐ¹ý(îêïÒÝ»ÝÂÛö)
  • Ouchterlony method
    ¿ìÅ©ÅÚ·Î´Ï ¹æ¹ý(Û°Ûö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • renal transplantation
    ½ÅÀ̽Ä
  • renal tubular acidosis
    ½Å´¢¼¼°ü»êÁõ
  • renal vein
    ½ÅÁ¤¸Æ
  • renal vein thrombosis
    ½ÅÁ¤¸ÆÇ÷ÀüÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
BLB Baker-Lima-Baker [mask]; Bessey-Lowry-Brock [method or unit]; black light bulb; Boothby-Lovelace-Bul...
BSAM basic sequential access method
CAM calf aortic microsome; cell adhesion molecule; cell-associating molecule; chorioallantoic membrane; ...
CPM central pontine myelinosis; chlorpheniramine maleate; continuous passive motion; critical path metho...
CPRAM controlled partial rebreathing anesthesia method
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CI Clearance
14C Clearance of
CLi Clearance of lithium
CL Clearance rate
C(Cr) Creatinine clearance
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • microfilm method
    ¹Ú¸·¹ý
  • mouth-to-mouth method
    Á¢±¸¹ý
  • Newton's method for uric acid
    ´º¿ìư ¿ä»ê Á¤·®¹ý
    »ê¼º ¿°È­Àº ħÀü¹ý¿¡ ÀÇÇØ °£¼· ¹°ÁúÀ» Á¦°ÅÇϰí, û»ê¿°À» È¥ÇÕÇÑ Çǰ˾×À» ºñ¼Ò ÅÖ½ºÅÙ ½Ã¾àÀ» 24½Ã°£ ½Ç¿Â¿¡¼­ ¹ÝÀÀ½ÃÄÑ ºñ»öÇÑ´Ù.
  • Nielsen's method
    ´Ò¼¾ Àΰø È£Èí¹ý
    ȯÀÚ¸¦ ¿ÞÂÊÀ¸·Î ¸ð·Î ´©À̰í, ¸Ó¸®¿¡ º£°³¸¦ ¹ÞÄ£ ´ÙÀ½, ¿ÞÂÊ ÆÈ´Ù¸®¸¦ ¾à°£ ±ÁÈù »óÅ¿¡¼­, ÈäºÎÀÇ ¾çÂÊÀ¸·ÎºÎÅÍ ¾Ð¹ÚÀ» °¡ÇØ È£±â¸¦ ÀÏÀ¸Å°°í, »ó¿ÏÀ» ¾ÕµÚ·Î ¿òÁ÷¿©¼­ Èí±â¸¦ ÀÏÀ¸Å°´Â ¹ý.
  • Nirenstein-Schiff's method
    ´Ï·»½ÃŸÀÎ ½ÃÇÁ ¹ý
    Æé½ÅÀÇ Á¤·®¹ýÀ¸·Î, ´Ü¹éÁúÀ» ÀÏÁ¤ ¿Âµµ¿Í ÀÏÁ¤ ½Ã°£ ³»¿¡ ¼ÒÈ­ÇÏ´Â ÈûÀ¸·Î½á ¿ª°¡¸¦ ÆÇÁ¤ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • Nissl's method
    ´Ï½½ ¿°»ö¹ý
    ½Å°æ ¼¼Æ÷ °ú¸³ÀÇ ¿°»ö¹ýÀ¸·Î, 90% ¾ËÄڿ÷ΠÁ¶Á÷À» °íÁ¤Çϰí, ´Ï½½ ¿°»ö¾×À¸·Î ¿°»öÇÑ ÈÄ 10% ¾Æ´Ò¸° ¾ËÄڿ÷ΠŻ»öÇÏ´Â ¹ý.
  • one probe method
    ´ÜÀÏ Å½ÃËÀÚ ¹æ½Ä
  • palladiometric method
    ÆÈ¶óµã ¹ý
  • paralleling method
    ÆòÇà¹ý
  • plate dilution method
    ÆòÆÇ Èñ¼®¹ý
  • Plummer's method
    Ç÷¯¸Ó¹ý
    °©»ó¼±Á¾ÀÇ ÃËÁø¹ýÀ¸·Î, Èä°ñ À¯µ¹±ÙÀÇ ÈĹæÀ¸·Î ¿Þ¼ÕÀ» ³ÖµÇ ¾öÁö¼Õ°¡¶ôÀ» ¾ÕÀ¸·Î ÇÏ¿© ¿ì¿±À» ¾Ð¹ÚÇϰí, ¿À¸¥¼ÕÀº ¿Þ¼Õ ÂÊÀ» ÇâÇØ ¾Ð¹ÚÇÏ´Â ¹ý.
  • powder-liquid method
    ºÐ, ¾×¹ý
  • precipitation method
    ħÀü¹ý
  • presaturation method
    ÀüÆ÷È­¹ý
  • quellung method
    ÆØÃ¢¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
renal ballottement A manoeuvre in which the kidney is moved by pressure from behind, allowing it to be felt between the hands and its size, shape, and mobility determined.
(05 Mar 2000)
renal blood flow, effective The amount of blood flowing to the parts of the kidney that are involved with the production of constituents of urine. It is that portion of the total renal blood flow that perfuses functional renal tissue (e.g., the glomeruli). It should be differentiated from renal plasma flow, effective which is based on the amount of plasma rather than on total renal blood.
(12 Dec 1998)
renal branch of lesser splanchnic nerve <anatomy, nerve> Branch of lesser splanchnic nerve to the aorticorenal plexus/ganglion.
Synonym: ramus renalis nervi splanchnici minoris.
(05 Mar 2000)
renal branch of vagus nerve <anatomy, nerve> Branches of vagus nerve to kidney via the coeliac plexus.
Synonym: rami renales nervi vagi.
(05 Mar 2000)
renal calcification <radiology> Nephrolithiasis, nephrocalcinosis, medullary (more common), cortical, neoplastic or inflammatory mass, renal cell carcinoma, XGP, tuberculosis
(12 Dec 1998)
renal calculi <radiology> Common: calcium phosphate (8%), calcium oxalate (most common: 73%, most opaque), magnesium ammonium phosphate (struvite), uncommon: diammonium calcium phosphate, magnesium phosphate, rare: cystine (faintly opaque; 1%), urate (lucent; 7%), xanthine see: matrix calculi
(12 Dec 1998)
renal calculus A calculus occurring within the kidney collecting system.
Synonym: nephrolith.
(05 Mar 2000)
renal cancer <radiology> About 8300 adults die each year from kidney cancer. An estimated 18100 new cases are diagnosed each year, comprising 2% of all cancers. The average age at diagnosis is 55-60 years., adenocarcinoma (hypernephroma), 80% of renal carcinoma, 66% male, associated with smoking, transitional cell or squamous carcinoma, 15% of renal carcinoma, 50% male, associated with calculous disease Excretory urography may reveal the primary lesion, the degree of local extension and evidence of compression or deviation of the ureter. REF: Rubin P. Clinical Oncology. Chapter 17.
(12 Dec 1998)
renal capsule The fibrous connective tissue that surrounds each kidney.
(12 Dec 1998)
renal carcinosarcoma <tumour> Obsolete term for Wilms' tumour.
(05 Mar 2000)
renal cast Any type of cast formed in a renal tubule, and found in the urine consisting of various materials, e.g., albumin, cells, blood.
Synonym: tube cast.
(05 Mar 2000)
renal cell cancer Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine. Also called renal cell carcinoma.
(12 Dec 1998)
renal cell carcinoma <oncology, tumour> The most common form of kidney cancer which occurs when the cells lining the renal tubule undergo cancerous changes. There are approximately 18,000 new cases of renal cell carcinoma (hypernephroma) per year in the U.S. With about 8,000 deaths annually.
Smoking is considered a major risk factor. Kidney dialysis patients are at increased risk for the development of hypernephroma. Family history for renal cell carcinoma is also considered a risk factor.
Symptoms include haematuria, flank pain, abdominal pain, back pain, weight loss and abdominal swelling.
(27 Sep 1997)
renal circulation The circulation of the blood through the vessels of the kidney.
(12 Dec 1998)
renal colic Severe colicky pain caused by the impaction or passage of a calculus in the ureter or renal pelvis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á